Literature DB >> 18427720

Decreased percentages of regulatory T cells in peripheral blood of patients with Behcet's disease before ocular attack: a possible predictive marker of ocular attack.

Yuki Nanke1, Shigeru Kotake, Mari Goto, Hiroshi Ujihara, Masao Matsubara, Naoyuki Kamatani.   

Abstract

The current study investigates the role of regulatory T (Treg) cells in the pathogenesis of ocular attack in patients with Behcet's disease (BD). Nineteen BD patients with ocular complications (BDo), including 11 BD patients with ocular attack (BDa) and eight BD patients with inactive ocular complications (BDi), were studied. Four BD patients without ocular complications (BDwo) were also evaluated as controls. All patients were prospectively followed by our outpatient clinic between autumn 2004 and spring 2005. CD4+ CD25+bright T cells (Treg cells) from peripheral blood were measured by flow cytometry. The percentages of Treg cells in CD4+ T cells from BDo were significantly decreased before ocular attack compared with those after ocular attack. Moreover, surprisingly, these levels before attack were significantly lower than normal level, whereas the percentages of Treg cells in both BDi and BDwo patients were normal. Treg cells were significantly decreased in BDa before active ocular attack. These findings suggest that Treg cells play an important role in ocular attack in BD patients. In addition, decreased percentages of Treg cells may be a predictive marker of ocular attack in BD patients allowing treatment of BD patients before an ocular attack.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18427720     DOI: 10.1007/s10165-008-0064-x

Source DB:  PubMed          Journal:  Mod Rheumatol        ISSN: 1439-7595            Impact factor:   3.023


  20 in total

Review 1.  Autoimmune uveitis: clinical, pathogenetic, and therapeutic features.

Authors:  Marcella Prete; Rosanna Dammacco; Maria Celeste Fatone; Vito Racanelli
Journal:  Clin Exp Med       Date:  2015-03-28       Impact factor: 3.984

2.  Tregs in Autoimmune Uveitis.

Authors:  Zhaohao Huang; Wenli Li; Wenru Su
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 3.  A look at autoimmunity and inflammation in the eye.

Authors:  Rachel R Caspi
Journal:  J Clin Invest       Date:  2010-09-01       Impact factor: 14.808

Review 4.  Current concepts and future directions in the pathogenesis and treatment of non-infectious intraocular inflammation.

Authors:  R W J Lee; A D Dick
Journal:  Eye (Lond)       Date:  2011-09-30       Impact factor: 3.775

Review 5.  Role of osteoclasts and interleukin-17 in the pathogenesis of rheumatoid arthritis: crucial 'human osteoclastology'.

Authors:  Shigeru Kotake; Toru Yago; Manabu Kawamoto; Yuki Nanke
Journal:  J Bone Miner Metab       Date:  2011-09-29       Impact factor: 2.626

Review 6.  Behcet's Syndrome.

Authors:  Sam R Dalvi; Resit Yildirim; Yusuf Yazici
Journal:  Drugs       Date:  2012-12-03       Impact factor: 9.546

7.  Regulatory T cells in Behçet's disease: is there a correlation with disease activity? Does regulatory T cell type matter?

Authors:  Eren Gündüz; Hava Usküdar Teke; Nazife Sule Yaşar Bilge; Döndü Usküdar Cansu; Cengiz Bal; Cengiz Korkmaz; Zafer Gülbaş
Journal:  Rheumatol Int       Date:  2013-08-03       Impact factor: 2.631

Review 8.  Effects of NSAIDs on Differentiation and Function of Human and Murine Osteoclasts - Crucial 'Human Osteoclastology'.

Authors:  Shigeru Kotake; Toru Yago; Manabu Kawamoto; Yuki Nanke
Journal:  Pharmaceuticals (Basel)       Date:  2010-05-11

9.  Aberrant Activation of Heat Shock Protein 60/65 Reactive T Cells in Patients with Behcet's Disease.

Authors:  Jun Shimizu; Tomoko Izumi; Noboru Suzuki
Journal:  Autoimmune Dis       Date:  2012-10-02

Review 10.  Skewed Helper T-Cell Responses to IL-12 Family Cytokines Produced by Antigen-Presenting Cells and the Genetic Background in Behcet's Disease.

Authors:  Jun Shimizu; Fumio Kaneko; Noboru Suzuki
Journal:  Genet Res Int       Date:  2013-12-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.